The highly anticipated novel Retatrutide 20mg device is now entering the market in the UK. As of now, access is restricted and primarily through specialist healthcare providers participating in clinical trials . Despite a full, widespread commercial rollout date remains unclear , early indications that individuals may be capable of obtain the drug